That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only one for which DOACs do not have a better risk profile ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
News Medical on MSN3h
Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patientsAbelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
The Healthy on MSN5mon
6 Silent Signs of AFib, According to a CardiologistAn irregular heartbeat can raise your risk for heart failure and stroke. With up to 6 million Americans estimated to have ...
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback